In Florida, California, and Illinois, researchers from several universities have found that two molecules in the immune system are crucial to drug resistance in breast cancers. Most breast cancer tumors are compelled by estrogen and drug treatments often include estrogen suppression, but unfortunately about half of patients don’t respond to those treatments. However, now that researchers know that two molecules, called interleukin 1 beta and tumor necrosis factor alpha, are responsible for the drug resistance in patients, it offers researchers key insights. Researchers hope to use the information and genomic, cellular and biochemical approaches to develop new treatments to block the resistance process for breast cancer patients.
Latest article
Pineapple pact shows fruits of collaboration on Earth Day
In California, Dole Packaged Foods has partnered with circular design firm Rais Case and Ananas Anam, creator of pineapple-based textile Piñatex®, to tackle pineapple...
Project converting chicken feathers into cultivated chicken meat concludes first phase
In Italy, a research project looking to grow cells from chicken feathers into chicken meat has concluded its first phase by generating a batch...
Vote for sustainability: Bioplastic dummy ballots used to spread voter awareness
In India, IIT Guwahati has developed 3D-printed dummy ballots made of biobased polylactic acid.
Commissioned by the Systematic Voters' Education and Electoral Participation Cell, the...